Impax Laboratories Reports Fourth Quarter and Full Year 2012 Results – Fort Mills Times

by admin on February 25, 2013

Impax Laboratories Reports Fourth Quarter and Full Year 2012 Results
Fort Mills Times
The Company recently completed its Phase IIb trial of its investigational drug candidate IPX159 in primary Restless Legs Syndrome (RLS). Analysis of the study data indicated that although the results showed a modest improvement in addressing RLS

and more »

View full post on restless leg syndrome – Google News

Leave a Comment

Previous post:

Next post: